Related Experiment Videos
Abstract:
One-year actuarial patient and graft survivals of 98% and 95% were obtained. Donor-specific transfusions were widely used in both the living-related donor kidney recipients as well as recipients of kidneys from distantly and unrelated individuals. The underlying health problems that are still endemic to this region will probably be reflected to a greater extent in longer term follow-up.